Comparison of Immune Checkpoint Inhibitor (ICI) Myocarditis and Non-ICI Myocarditis Using Cardiovascular Magnetic Resonance: A Single-Centre Retrospective Observational Study.
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
54 patients ( = 26 ICI myocarditis; = 28 non-ICI myocarditis) underwent clinical CMR for the assessment of cardiac function (cines), myocardial fibrosis (native T1-mapping, extracellular volume [ECV] fraction, late gadolinium enhancement [LGE]) and myocardial oedema (native T2-mapping).
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
non-ICI myocarditis. Further work is needed to assess the value of CMR for diagnosing standalone ICI myocarditis.
: Differentiating between immune checkpoint inhibitor (ICI) myocarditis and non-ICI myocarditis is clinically important.
APA
Jacobs E, Yip A, et al. (2025). Comparison of Immune Checkpoint Inhibitor (ICI) Myocarditis and Non-ICI Myocarditis Using Cardiovascular Magnetic Resonance: A Single-Centre Retrospective Observational Study.. Journal of clinical medicine, 14(21). https://doi.org/10.3390/jcm14217809
MLA
Jacobs E, et al.. "Comparison of Immune Checkpoint Inhibitor (ICI) Myocarditis and Non-ICI Myocarditis Using Cardiovascular Magnetic Resonance: A Single-Centre Retrospective Observational Study.." Journal of clinical medicine, vol. 14, no. 21, 2025.
PMID
41227207
Abstract
: Differentiating between immune checkpoint inhibitor (ICI) myocarditis and non-ICI myocarditis is clinically important. Cardiovascular magnetic resonance (CMR) is a well-established method for diagnosing acute myocarditis. The value of CMR for distinguishing ICI myocarditis from non-ICI myocarditis remains unclear, which this study sought to determine. : A total of 54 patients ( = 26 ICI myocarditis; = 28 non-ICI myocarditis) underwent clinical CMR for the assessment of cardiac function (cines), myocardial fibrosis (native T1-mapping, extracellular volume [ECV] fraction, late gadolinium enhancement [LGE]) and myocardial oedema (native T2-mapping). : ICI myocarditis patients were older than non-ICI myocarditis patients (75 years [71-78] vs. 39 years [30-64]; < 0.001). Both groups had similar left ventricular (LV) ejection fraction (58 ± 11% vs. 58 ± 6%; = 0.970). ICI myocarditis and non-ICI myocarditis patients also had similar native myocardial T1 values (1041 ± 84 ms vs. 1063 ± 60 ms; = 0.281), native myocardial T2 values (59 ± 6 ms vs. 59 ± 6 ms; = 0.943) and ECV (0.32 ± 0.07 vs. 0.31 ± 0.04; = 0.403). Native myocardial T1 values (Rho = -0.553) and ECV (Rho = -0.502) were significantly associated with LVEF in non-ICI myocarditis patients (both < 0.05). There was no significant association between myocardial T1 values, T2 values or ECV, with LVEF, in ICI myocarditis patients (all < 0.05). Non-ICI myocarditis patients had a greater frequency of LGE in the LV compared to ICI myocarditis patients (89% vs. 52% = 0.005). However, the pattern of LGE was similar between the two patient groups (mostly subepicardial and/or mid-wall). : In this single centre retrospective cohort, the findings suggest that quantitative parametric mapping methods by CMR may not differentiate between ICI vs. non-ICI myocarditis. Further work is needed to assess the value of CMR for diagnosing standalone ICI myocarditis.
🏷️ 키워드 / MeSH
같은 제1저자의 인용 많은 논문 (3)
- Incidence and Outcomes of Metastatic Patterns of Pancreatic Ductal Adenocarcinoma.
- Novel Combination of Irreversible Electroporation and Allogenic Chimeric Antigen Receptor T-Cell Therapy Synergizes Therapeutic Outcomes in a Preclinical Human Pancreatic Cancer Mouse Model.
- Novel combination of irreversible electroporation and allogenic chimeric antigen receptor (CAR) T-cell therapy synergizes therapeutic outcomes in a preclinical human pancreatic cancer mouse model.